Book Cover
Home  |   Healthcare   |  Adalimumab Biosimilar Market

Adalimumab Biosimilar Market Size, Share, Growth, and Industry Analysis, By Type ( Exemptia,Adalirel,Cipleumab,Others ), By Application ( Hospital Pharmacy,Retail Pharmacy,Online Pharmacy ), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US
Detailed TOC of Global Adalimumab Biosimilar Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

Table of Content

1 Adalimumab Biosimilar Market Overview
1.1 Product Overview and Scope of Adalimumab Biosimilar Market
1.2 Adalimumab Biosimilar Market Segment by Type
1.2.1 Global Adalimumab Biosimilar Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Adalimumab Biosimilar Market Segment by Application
1.3.1 Adalimumab Biosimilar Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Adalimumab Biosimilar Market, Region Wise (2017-2027)
1.4.1 Global Adalimumab Biosimilar Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.3 Europe Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.4 China Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.5 Japan Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.6 India Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.8 Latin America Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.5 Global Market Size of Adalimumab Biosimilar (2017-2027)
1.5.1 Global Adalimumab Biosimilar Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Adalimumab Biosimilar Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Adalimumab Biosimilar Market

2 Industry Outlook
2.1 Adalimumab Biosimilar Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Adalimumab Biosimilar Market Drivers Analysis
2.4 Adalimumab Biosimilar Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Adalimumab Biosimilar Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Adalimumab Biosimilar Industry Development

3 Global Adalimumab Biosimilar Market Landscape by Player
3.1 Global Adalimumab Biosimilar Sales Volume and Share by Player (2017-2022)
3.2 Global Adalimumab Biosimilar Revenue and Market Share by Player (2017-2022)
3.3 Global Adalimumab Biosimilar Average Price by Player (2017-2022)
3.4 Global Adalimumab Biosimilar Gross Margin by Player (2017-2022)
3.5 Adalimumab Biosimilar Market Competitive Situation and Trends
3.5.1 Adalimumab Biosimilar Market Concentration Rate
3.5.2 Adalimumab Biosimilar Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion

4 Global Adalimumab Biosimilar Sales Volume and Revenue Region Wise (2017-2022)
4.1 Global Adalimumab Biosimilar Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Adalimumab Biosimilar Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Adalimumab Biosimilar Market Under COVID-19
4.5 Europe Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Adalimumab Biosimilar Market Under COVID-19
4.6 China Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Adalimumab Biosimilar Market Under COVID-19
4.7 Japan Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Adalimumab Biosimilar Market Under COVID-19
4.8 India Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Adalimumab Biosimilar Market Under COVID-19
4.9 Southeast Asia Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Adalimumab Biosimilar Market Under COVID-19
4.10 Latin America Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Adalimumab Biosimilar Market Under COVID-19
4.11 Middle East and Africa Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Adalimumab Biosimilar Market Under COVID-19

5 Global Adalimumab Biosimilar Sales Volume, Revenue, Price Trend by Type
5.1 Global Adalimumab Biosimilar Sales Volume and Market Share by Type (2017-2022)
5.2 Global Adalimumab Biosimilar Revenue and Market Share by Type (2017-2022)
5.3 Global Adalimumab Biosimilar Price by Type (2017-2022)
5.4 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate of Exemptia (2017-2022)
5.4.2 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate of Adalirel (2017-2022)
5.4.3 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate of Cipleumab (2017-2022)
5.4.4 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate of Others (2017-2022)

6 Global Adalimumab Biosimilar Market Analysis by Application
6.1 Global Adalimumab Biosimilar Consumption and Market Share by Application (2017-2022)
6.2 Global Adalimumab Biosimilar Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Adalimumab Biosimilar Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Adalimumab Biosimilar Consumption and Growth Rate of Hospital Pharmacy (2017-2022)
6.3.2 Global Adalimumab Biosimilar Consumption and Growth Rate of Retail Pharmacy (2017-2022)
6.3.3 Global Adalimumab Biosimilar Consumption and Growth Rate of Online Pharmacy (2017-2022)

7 Global Adalimumab Biosimilar Market Forecast (2022-2027)
7.1 Global Adalimumab Biosimilar Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Adalimumab Biosimilar Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Adalimumab Biosimilar Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Adalimumab Biosimilar Price and Trend Forecast (2022-2027)
7.2 Global Adalimumab Biosimilar Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Adalimumab Biosimilar Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Adalimumab Biosimilar Revenue and Growth Rate of Exemptia (2022-2027)
7.3.2 Global Adalimumab Biosimilar Revenue and Growth Rate of Adalirel (2022-2027)
7.3.3 Global Adalimumab Biosimilar Revenue and Growth Rate of Cipleumab (2022-2027)
7.3.4 Global Adalimumab Biosimilar Revenue and Growth Rate of Others (2022-2027)
7.4 Global Adalimumab Biosimilar Consumption Forecast by Application (2022-2027)
7.4.1 Global Adalimumab Biosimilar Consumption Value and Growth Rate of Hospital Pharmacy(2022-2027)
7.4.2 Global Adalimumab Biosimilar Consumption Value and Growth Rate of Retail Pharmacy(2022-2027)
7.4.3 Global Adalimumab Biosimilar Consumption Value and Growth Rate of Online Pharmacy(2022-2027)
7.5 Adalimumab Biosimilar Market Forecast Under COVID-19

8 Adalimumab Biosimilar Market Upstream and Downstream Analysis
8.1 Adalimumab Biosimilar Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Adalimumab Biosimilar Analysis
8.6 Major Downstream Buyers of Adalimumab Biosimilar Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Adalimumab Biosimilar Industry

9 Players Profiles
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.1.3 Boehringer Ingelheim Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Sandoz
9.2.1 Sandoz Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.2.3 Sandoz Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Oncobiologics
9.3.1 Oncobiologics Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.3.3 Oncobiologics Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Samsung Bioepsis
9.4.1 Samsung Bioepsis Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.4.3 Samsung Bioepsis Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 AET BioTech
9.5.1 AET BioTech Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.5.3 AET BioTech Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 LG Life Sciences/Mochida Pharmaceutical
9.6.1 LG Life Sciences/Mochida Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.6.3 LG Life Sciences/Mochida Pharmaceutical Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Zydus Cadila
9.7.1 Zydus Cadila Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.7.3 Zydus Cadila Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Momenta Pharmaceuticals
9.8.1 Momenta Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.8.3 Momenta Pharmaceuticals Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Amgen
9.9.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.9.3 Amgen Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Fujifilm Kyowa Kirin Biologics
9.10.1 Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.10.3 Fujifilm Kyowa Kirin Biologics Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Pfizer
9.11.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.11.3 Pfizer Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Coherus Biosciences
9.12.1 Coherus Biosciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.12.3 Coherus Biosciences Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source

?

Captcha refresh

Trusted & Certified

Our Clients